Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Validating A Model To Predict Disease Progression Outcomes In Patients With COPD.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Comparative Effectiveness of Treatments for Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL), Using Matching Adjusted Indirect Comparison.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2.

Molecular psychiatry·2013
Same author

Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.

The pharmacogenomics journal·2010
Same author

Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT.

Bone marrow transplantation·2008
Same author

Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen.

Bone marrow transplantation·2007

相关实验视频

Updated: Jul 6, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

混合的淋巴血液构造奇默症和移植与淋巴瘤效应后,非骨髓剥离疗法和HLA不匹配的骨髓移植.

M Sykes1, F Preffer, S McAfee

  • 1Transplantation Biology Research Center, Surgical Service, Massachusetts General Hospital and Harvard Medical School, Boston 02129, USA. sykes@helix.mgh.harvard.edu

Lancet (London, England)
|May 29, 1999
PubMed
概括

这项研究表明,非骨髓缩性调节可以在HLA不匹配的骨髓移植中实现混合的奇默,可能提供强大的抗淋巴瘤益处,减少了移植与宿主疾病 (GVHD).

更多相关视频

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

相关实验视频

Last Updated: Jul 6, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

科学领域:

  • 血液学 血液学 血液学
  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.

背景情况:

  • 在HLA不匹配的骨髓移植中,标准的骨髓损伤条件导致严重的移植对宿主疾病 (GVHD) 和移植失败.
  • 为了减轻这些并发症,研究了一种新型的非骨髓折缩条件方法.
  • 这项研究的目的是诱导淋巴血液构成的移植对宿主反应,而不会过度的GVHD.

研究的目的:

  • 评估一种非骨髓衰变性调节方案在诱导跨越HLA障碍物混合奇默的疗效.
  • 评估这种方法在耐火性非霍奇金淋巴瘤患者中的安全性和治疗潜力.

主要方法:

  • 五名患有耐火性非霍奇金淋巴瘤的患者接受了来自 haploidentical 相关捐赠者的骨髓移植.
  • 调节涉及环胺,胸膜辐射和抗细胞球蛋白.
  • 环素被用作唯一的GVHD预防药物.

主要成果:

  • 在五名患者中,有四名患者实现了移植,并建立了混合的造血混凝土.
  • 观察到捐赠者淋巴细胞组织的占主导地位和可变的骨髓细胞混凝土.
  • 两名患者实现了无GVHD缓解 (完全和部分).

结论:

  • 非骨髓缩条件可以在HLA不匹配的骨髓移植中成功诱导混合奇默.
  • 观察到的抗淋巴瘤反应表明,在没有骨髓衰竭条件的情况下,异构移植具有潜在的免疫治疗益处.